Cargando…
Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications
Patients experiencing financial distress as a side-effect of cancer are not only reported in the United States, but also in third-party payer healthcare systems in Europe. Since validated survey instruments are a prerequisite for robust and comparable results, we aimed to compile and classify availa...
Autores principales: | Witte, J, Mehlis, K, Surmann, B, Lingnau, R, Damm, O, Greiner, W, Winkler, E C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637374/ https://www.ncbi.nlm.nih.gov/pubmed/31046080 http://dx.doi.org/10.1093/annonc/mdz140 |
Ejemplares similares
-
The patient-level effect of the cost of Cancer care – financial burden in German Cancer patients
por: Mehlis, Katja, et al.
Publicado: (2020) -
Patient-Reported Financial Distress in Cancer: A Systematic Review of Risk Factors in Universal Healthcare Systems
por: Pauge, Sophie, et al.
Publicado: (2021) -
Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer
por: Honda, Kazunori, et al.
Publicado: (2019) -
Financial Toxicity
por: Nogueira, Luciana de Alcantara, et al.
Publicado: (2020) -
Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
por: de Souza, Jonas A., et al.
Publicado: (2016)